The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Actinium Pharmaceuticals, Inc(NYSE MKT:ATNM) 
Actinium Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplant (BMT) or a type of cellular therapy, and for other adoptive cell therapies. Its lead product candidate, I-131 apamistamab (Iomab-B) that is in a ...
Actinium Pharmaceuticals Days Payable Outstanding ttm (DPO)
Actinium Pharmaceuticals Op Cashflow Per Share ttm
Actinium Pharmaceuticals Free Cashflow Per Share ttm
Actinium Pharmaceuticals Cash Per Share ttm
Actinium Pharmaceuticals P/S ratio ttm
Actinium Pharmaceuticals (GAAP) P/E ratio ttm
Actinium Pharmaceuticals P/B ratio ttm
No extra charts and metrics for this ticker.